Abstract

Summary

This paper investigates how rapid-acting antidepressants interact with circadian clock machinery, highlighting the peri-habenular nucleus as a newly identified bridge between ipRGCs and mood-regulating brain circuits. For lighting designers and clinicians, this suggests that light-based interventions targeting ipRGC pathways may complement or enhance pharmacological antidepressant treatments.
Abstract

Key Findings

  • The peri-habenular nucleus is identified as a novel region linking ipRGC light signals to antidepressant-relevant brain circuits.
  • Rapid-acting antidepressants (e.g., ketamine) appear to interact with circadian clock gene mechanisms, suggesting time-of-day administration may influence treatment efficacy.
  • ipRGC-mediated light pathways are implicated in mood regulation, supporting a biological basis for light therapy in depression treatment.
Categories

Categories

Mood & Mental Wellness: Examines mechanisms linking circadian biology and rapid-acting antidepressants, with implications for treatment timing and light-based interventions.
Sleep & Circadian Health: Explores the role of circadian clock mechanisms, including ipRGC pathways, in mediating antidepressant effects.
The Science of Light: Discusses intrinsically photosensitive retinal ganglion cells (ipRGCs) and the peri-habenular nucleus as a novel neural link between light input and mood regulation.
Authors

Author(s)

S Sato, B Bunney, L Mendoza-Viveros
Publication Date

Publication Year

2022
Citations

Number of Citations

29
View more publications